PharmacyCodes



Dihydergot en es it fr

Dihydergot Brand names, Dihydergot Analogs

Dihydergot Brand Names Mixture

  • No information avaliable

Dihydergot Chemical_Formula

C33H37N5O5

Dihydergot RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Dihydergot fda sheet

Dihydergot FDA

Dihydergot msds (material safety sheet)

Dihydergot MSDS

Dihydergot Synthesis Reference

No information avaliable

Dihydergot Molecular Weight

583.678 g/mol

Dihydergot Melting Point

No information avaliable

Dihydergot H2O Solubility

No information avaliable

Dihydergot State

Solid

Dihydergot LogP

No information avaliable

Dihydergot Dosage Forms

Liquid

Dihydergot Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Dihydergot Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Dihydergot Absorption

Interpatient variable and may be dependent on the administration technique

Dihydergot side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Dihydergot Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45� (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Dihydergot Organisms Affected

Humans and other mammals